about
Drug development, radiolabelled drugs and PET.Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.Role of scintimammography in assessing the response of neoadjuvant chemotherapy in locally advanced breast cancerMolecular imaging of gene expression and protein function in vivo with PET and SPECT.PET imaging of multidrug resistance in tumors using 18F-fluoropaclitaxel.Imaging reversal of multidrug resistance in living mice with bioluminescence: MDR1 P-glycoprotein transports coelenterazineScintimammography for the detection of breast cancer.Comparison of (99m)Tc-sestamibi and doxorubicin to monitor inhibition of P-glycoprotein function.Effect of Ritonavir on (99m)Technetium-Mebrofenin Disposition in Humans: A Semi-PBPK Modeling and In Vitro Approach to Predict Transporter-Mediated DDIsEffect of trifluoperazine on Tc-99m sestamibi uptake in patients with advanced nonsmall cell lung cancer.Dual-phase 99mTc-MIBI imaging and the expressions of P-gp, GST-π, and MRP1 in hyperparathyroidism.Assessing p-glycoprotein (Pgp) activity in vivo utilizing 68Ga-Schiff base complexes.Comparison of the expression of P-glycoprotein, Ki-67, and P-53 to technetium-99m tetrofosmin mammoscintigraphic findings.Imaging Multidrug Resistance in Hematological Malignancies.Expression of multidrug-resistance P-glycoprotein (MDR1) in human brain tumors.Expression of permeability-glycoprotein (P-gp) and uptake of technetium-99m-hexakis-2-methoxy-isobutyl-isonitrile (99Tcm-MIBI) in malignant tumour of the head and neck.Scintigraphy for interpretation of malignant tumours of the head and neck: comparison of technetium-99m-hexakis-2-methoxyisobutylisonitrile (Tc-MIBI) and thallium-201-chloride (Tl-201).Technetium-99m-sestamethoxyisobutylisonitrile scan as a predictor of chemotherapy response in malignant lymphomas compared with P-glycoprotein expression, multidrug resistance-related protein expression and other prognosis factors.
P2860
Q33841662-E80A100C-81CD-4A99-BC1C-F97DB9BD1622Q34119201-005F270C-D7E8-465A-8971-C92BD76156F0Q34675752-62BFBFD8-B865-4120-9F92-11C2175DA4A3Q34918519-C36DCA6E-E8AC-4336-8800-30C4EB546104Q35575502-92F2A1DD-12E4-4430-8F46-49465B8CC9D7Q36161579-DA9A144C-3804-41F7-988C-5943210A9D7DQ36315046-DD89B868-4C2F-451B-9B70-75B7B372E25AQ36622566-41125C53-A3ED-40B0-816D-35BF33D3CA87Q36693701-8FEE20FF-8D22-4D38-86CD-E92BADAC43B8Q36749620-08F069F4-62FD-47B9-8096-8832A8F2F78EQ38625855-DD6CB258-80C4-48E9-9619-9443BF289C33Q39658254-61D3D8BD-F285-4A7E-B1DC-6C5C8F155F6DQ43922191-BF425216-681C-4212-BCBA-3CAAFA1D87AEQ47683128-CD74AD80-E3E3-4D3F-A32A-3007F1DA792AQ48857140-61E787FC-87C0-44E1-9F0D-837992D4D1E9Q53659976-5C918E13-D51A-4078-8AFE-297CB21F8A50Q53659980-71F2E246-977C-4F0D-A8B7-2D84D1C71053Q54005290-C636D090-4CEB-4435-8E75-7AAD09C0CEC3
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Visualization of multidrug resistance in vivo.
@ast
Visualization of multidrug resistance in vivo.
@en
Visualization of multidrug resistance in vivo.
@nl
type
label
Visualization of multidrug resistance in vivo.
@ast
Visualization of multidrug resistance in vivo.
@en
Visualization of multidrug resistance in vivo.
@nl
prefLabel
Visualization of multidrug resistance in vivo.
@ast
Visualization of multidrug resistance in vivo.
@en
Visualization of multidrug resistance in vivo.
@nl
P2093
P356
P1476
Visualization of multidrug resistance in vivo.
@en
P2093
Franssen EJ
Hendrikse NH
Vaalburg W
de Vries EG
van der Graaf WT
P2888
P304
P356
10.1007/S002590050390
P577
1999-03-01T00:00:00Z